Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Lactate Dehydrogenase to Carboxyhemoglobin Ratio As a Biomarker of Heme Release to Heme Processing Is Associated with Higher Tricuspid Regurgitant Jet Velocity and Early Death in Sickle Cell Disease

Annelies J. Van Vuren, MD, Laurel Mendelsohn, BS, Richard van Wijk, PhD, Caterina P. Minniti, MD, John Baird, MD, Gregory J Kato, MD, Eduard J. van Beers, MD PhD

Blood (2019) 134 (Supplement_1): 2274.

https://doi.org/10.1182/blood-2019-124048

Published: 2019

Journal Articles

Normal Hemoglobin Concentrations in Obstructive Sleep Apnea and Associated Neocytolysis-Mediated Hemolysis and Inflammation Mediated Suppression of Expected Elevated Hemoglobin

Jihyun Song, PhD, Krishna M Sundar, MD, Monika Horvathova, MSc, PhD, Tsewang Tashi, MD, Carsten Lundby, PhD, Tomas Ganz, MD PhD, Josef T. Prchal, MD

Blood (2019) 134 (Supplement_1): 3507.

https://doi.org/10.1182/blood-2019-131269

Published: 2019

Journal Articles

Interest of a New Method for Free Plasma Heme Related Species Dosages in Sickle Cell Disease and Beta Thalassemia

Laurent Kiger, Sandia Adypagavane, Laura Bencheikh, PhD, Nicolas Hebert, Stephane Moutereau, MD, Frédéric Galactéros, MD PhD, Michael Marden, PhD, Yves Beuzard, MD, France Pirenne, MD PhD, Pablo Bartolucci, MD PhD

Blood (2019) 134 (Supplement_1): 3381.

https://doi.org/10.1182/blood-2019-130600

Published: 2019

Journal Articles

Protective Effects of Carbon Monoxide Delivered By Corm-401 in Hyperhemolysis in Patients with Sickle Cell Disease

Nguyen-Peyre Kim-Anh, PhD, Bodivit Gwellaouen, Foresti Roberta, PhD, Kiger Laurent, PhD, Gaetana Di Liberto, PhD, Philippe Chadebech, PhD, Alicia Jouard, Sadaf Pakdaman, Seguin Marion, Marden Micheal, PhD, France Pirenne, MD PhD, Motterlini Roberto, PhD, Pablo Bartolucci, MD PhD

Blood (2018) 132 (Supplement 1): 2367.

https://doi.org/10.1182/blood-2018-99-112900

Published: 2018

Journal Articles

Pegylated Carboxyhemoglobin (SANGUINATE ® ) Restores Blood Flow and Tissue Oxygenation in a Novel Rat Model of Acute Vaso-Occlusive Crisis

Bjorn K. Song, PhD, William H. Nugent, PhD

Blood (2017) 130 (Supplement 1): 3517.

https://doi.org/10.1182/blood.V130.Suppl_1.3517.3517

Published: 2017

Journal Articles

Oral Carbon Monoxide Therapy in Murine Models of Sickle Cell Disease: Beneficial Effects on Vaso-Occlusion, Inflammation and Anemia

John D Belcher, PhD, Edward Gomperts, MD, Julia Nguyen, BS, Chunsheng Chen, MD, Fuad Abdulla, Hao Nguyen, Tran Vo, Karina Bursch, Zachary M Kiser, PhD, Howard Levy, MDPhD, Leo E Otterbein, PhD, Gregory M Vercellotti, MD FACP

Blood (2017) 130 (Supplement 1): 2232.

https://doi.org/10.1182/blood.V130.Suppl_1.2232.2232

Published: 2017

Journal Articles

Pegylated Carboxyhemoglobin Bovine (SANGUINATE ® ) Restores RBCs Roundness and Reduces Pain during a Sickle Cell Vaso-Occlusive Crisis

Peter Buontempo, MSc, Ronald G. Jubin, PhD, Cathy Buontempo, Rosa Real, MD, Friedericke Kazo, MSc, Siobhan O'Brien, Faiza Adeel, Abraham Abuchowski, PhD

Blood (2017) 130 (Supplement 1): 969.

https://doi.org/10.1182/blood.V130.Suppl_1.969.969

Published: 2017

Journal Articles

Infusion of Pegylated Bovine Carboxyhemoglobin (PEG-COHb) Is Associated with Rapid Reversal of Progressive Acute Chest Syndrome in a Jehovah's Witness Patient with Hemoglobin SC Sickle Cell Disease

Roberta Miyeko Kato, MD, Thomas Hofstra, MD, Herbert J. Meiselman, ScD, Henry Jay Forman, PhD, Abe Abuchowski, PhD, Deven V. Parmar, MD, Thomas D. Coates, MD

Blood (2015) 126 (23): 4541.

https://doi.org/10.1182/blood.V126.23.4541.4541

Published: 2015

Journal Articles

Moderate Exercise Training Attenuates Inflammation in Transgenic Sickle Cell Mice

Emmanuelle Charrin, Cyril Martin, PhD, John Dube, PhD, Philippe Connes, PhD, Vincent Pialoux, PhD, Solomon Fiifi Ofori-Acquah, PhD

Blood (2015) 126 (23): 976.

https://doi.org/10.1182/blood.V126.23.976.976

Published: 2015

Journal Articles

Peg-Cohb Mediated Carbon Monoxide and Oxygen Transfer to Hypoxic Red Blood Cells Prevent, Slow, and/or Reverse Sickling in Vitro.

Peter Buontempo, MSc, BSc, Rick Yglesias, Yuli Chen, Catherine Buontempo, Ronald G. Jubin, PhD, Abraham Abuchowski, PhD

Blood (2015) 126 (23): 967.

https://doi.org/10.1182/blood.V126.23.967.967

Published: 2015

Journal Articles

Successful Use of Pegylated Carboxyhemoglobin Bovine As an Emergency Treatment for Severe Anemia in a Patient with Sickle Cell Disease and Hyperhemolysis: A Case Report

Candice M Nalley, MD, Abe Abuchowski, PhD MHS, Steven Hsu, MD, Sophie Lanzkron, MD MHS

Blood (2014) 124 (21): 4928.

https://doi.org/10.1182/blood.V124.21.4928.4928

Published: 2014

Journal Articles

Rapid Reversal of Red Blood Cell Sickling Promoted By Pegylated Carboxyhemoglobin Bovine Gas Transfer Properties

Ronald Jubin, PhD, Peter Buontempo, MSc, BSc, Ricardo A Yglesias, BA, MS, Abe Abuchowski, PhD MHS, Yuli Chen, BS, MS, Glenn Kazo, MS, Friedericke Kazo, MS

Blood (2014) 124 (21): 1372.

https://doi.org/10.1182/blood.V124.21.1372.1372

Published: 2014

Journal Articles

Safety and Tolerability Of MP4CO: A Dose Escalation Study In Stable Patients With Sickle Cell Disease

Jo Howard, MB, BChir, MRCP, FRCPath, Swee Lay Thein, MBBS, DSc, Frederic Galacteros, MD PhD, Adlette Inati, MD, Marvin Reid, PhD, Peter E. Keipert, PhD, Tania N. Small, MD, Frank Booth, MA MSc BM BCh FACS

Blood (2013) 122 (21): 2205.

https://doi.org/10.1182/blood.V122.21.2205.2205

Published: 2013

Journal Articles

The Pharmacokinetic Evaluation Of Oral Administered Carbon Monoxide Instilled In a Liquid Formulation (CO-LF) To Rats To Determine Carbon Monoxide Hemoglobin Levels With Potential Efficacy In Patients With Sickle Cell Disease (SCD)

Edward D. Gomperts, MD, Martin I Lee, PhD, Henry J Forman, PhD, Honglei Liu, MD

Blood (2013) 122 (21): 3431.

https://doi.org/10.1182/blood.V122.21.3431.3431

Published: 2013

Journal Articles

Prevention of Venular Stasis, Circulatory Collapse and Mortality in Transgenic Sickle Mice Administered MP4CO, a Pegylated Hemoglobin Saturated with Carbon Monoxide

John D Belcher, PhD, Chunsheng Chen, PhD, Mark Young, PhD, Phuc Tran, Gregory M Vercellotti, MD

Blood (2011) 118 (21): 850.

https://doi.org/10.1182/blood.V118.21.850.850

Published: 2011

Journal Articles

Carbon Monoxide Therapy Reduces Reactive Oxygen Species Production and the Short-Term Hematopoietic Stem Cell Population In Heme-Oxygenase-1 Knockout Mice

Joan D. Beckman, PhD, Paul H Marker, MS, Julia Nguyen, John D Belcher, Ph.D., Robert P Hebbel, MD, Anthony J. Croatt, Karl A. Nath, MD, Gregory M. Vercellotti, MD

Blood (2010) 116 (21): 4767.

https://doi.org/10.1182/blood.V116.21.4767.4767

Published: 2010

Journal Articles

The Impact of Local Air Quality on the Number of Hospital Admissions with Acute Pain in Sickle Cell Disease within an Urban Environment.

Deborah Yallop, MRCP, Edward R. Duncan, MB BChir, Ellie Norris, Gary Fuller, Nikki Thomas, MSc, Joan Walters, MSc, Moira C. Dick, FRCP, Susan E. Height, MD, Swee Lay Thein, MD, David C. Rees, FRCP

Blood (2006) 108 (11): 3790.

https://doi.org/10.1182/blood.V108.11.3790.3790

Published: 2006

Journal Articles

Some Characteristic Properties of Hemoglobin C

T. H. J. HUISMAN, P. C. VAN DER SCHAAF, A. VAN DER SAR

Blood (1955) 10 (11): 1079–1091.

https://doi.org/10.1182/blood.V10.11.1079.1079

Published: 1955

NARROW

Lactate Dehydrogenase to Carboxyhemoglobin Ratio As a Biomarker of Heme Release to Heme Processing Is Associated with Higher Tricuspid Regurgitant Jet Velocity and Early Death in Sickle Cell Disease

Normal Hemoglobin Concentrations in Obstructive Sleep Apnea and Associated Neocytolysis-Mediated Hemolysis and Inflammation Mediated Suppression of Expected Elevated Hemoglobin

Interest of a New Method for Free Plasma Heme Related Species Dosages in Sickle Cell Disease and Beta Thalassemia

Protective Effects of Carbon Monoxide Delivered By Corm-401 in Hyperhemolysis in Patients with Sickle Cell Disease

Pegylated Carboxyhemoglobin (SANGUINATE ® ) Restores Blood Flow and Tissue Oxygenation in a Novel Rat Model of Acute Vaso-Occlusive Crisis

Oral Carbon Monoxide Therapy in Murine Models of Sickle Cell Disease: Beneficial Effects on Vaso-Occlusion, Inflammation and Anemia

Pegylated Carboxyhemoglobin Bovine (SANGUINATE ® ) Restores RBCs Roundness and Reduces Pain during a Sickle Cell Vaso-Occlusive Crisis

Infusion of Pegylated Bovine Carboxyhemoglobin (PEG-COHb) Is Associated with Rapid Reversal of Progressive Acute Chest Syndrome in a Jehovah's Witness Patient with Hemoglobin SC Sickle Cell Disease

Moderate Exercise Training Attenuates Inflammation in Transgenic Sickle Cell Mice

Peg-Cohb Mediated Carbon Monoxide and Oxygen Transfer to Hypoxic Red Blood Cells Prevent, Slow, and/or Reverse Sickling in Vitro.

Successful Use of Pegylated Carboxyhemoglobin Bovine As an Emergency Treatment for Severe Anemia in a Patient with Sickle Cell Disease and Hyperhemolysis: A Case Report

Rapid Reversal of Red Blood Cell Sickling Promoted By Pegylated Carboxyhemoglobin Bovine Gas Transfer Properties

Safety and Tolerability Of MP4CO: A Dose Escalation Study In Stable Patients With Sickle Cell Disease

The Pharmacokinetic Evaluation Of Oral Administered Carbon Monoxide Instilled In a Liquid Formulation (CO-LF) To Rats To Determine Carbon Monoxide Hemoglobin Levels With Potential Efficacy In Patients With Sickle Cell Disease (SCD)

Prevention of Venular Stasis, Circulatory Collapse and Mortality in Transgenic Sickle Mice Administered MP4CO, a Pegylated Hemoglobin Saturated with Carbon Monoxide

Carbon Monoxide Therapy Reduces Reactive Oxygen Species Production and the Short-Term Hematopoietic Stem Cell Population In Heme-Oxygenase-1 Knockout Mice

The Impact of Local Air Quality on the Number of Hospital Admissions with Acute Pain in Sickle Cell Disease within an Urban Environment.

Some Characteristic Properties of Hemoglobin C

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only